Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Indian researchers describe new anticancer agent

Jan. 14, 1998

Korean researchers discover new PLC and PI turnover inhibitor from fungal strain

Jan. 14, 1998

U.S. marketing application submitted for AD-32

Jan. 14, 1998

Photofrin enters phase III testing for new indication

Jan. 14, 1998

New anticancer combination associated with high efficacy in phase II metastatic breast cancer trial

Jan. 13, 1998

Analog II: a novel antiestrogen with selective activity against breast cancer

Jan. 13, 1998

Temodal submitted for approval in E.U.

Jan. 13, 1998

Potent, selective protein tyrosine kinase inhibitors for immune and hyperproliferative disorders

Jan. 13, 1998

Chemogene therapy: a new therapeutic approach on the horizon?

Jan. 13, 1998

CDK inhibitor induces apoptosis and tumor necrosis in a dog with malignant melanoma

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...